Ju Yi Lin
Director of Finance/CFO bij FORMOSA PHARMACEUTICALS, INC.
Profiel
Ju Yi Lin is currently the Controller at TLC Biopharmaceuticals, Inc. and the Chief Financial Officer & Head-Accounting at Formosa Pharmaceuticals, Inc. She is also the Deputy General Manager-Administration at Pharmosa Biopharm, Inc. Previously, she worked as the Accounting Manager at Ma Laboratories, Inc. and NextGen Communications LLC.
She was also the CFO & Vice President at Taiwan Liposome Co., Ltd.
from 2005 to 2020.
Ms. Lin holds an MBA from the University of California, Riverside and an undergraduate degree from Soochow University.
Actieve functies van Ju Yi Lin
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMOSA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01-12-2020 |
| PHARMOSA BIOPHARM INC. | Chief Administrative Officer | 01-06-2015 |
| TLC Biopharmaceuticals, Inc. | Comptroller/Controller/Auditor | - |
Eerdere bekende functies van Ju Yi Lin
| Bedrijven | Functie | Einde |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Director of Finance/CFO | 31-08-2020 |
NextGen Communications LLC
 NextGen Communications LLC Specialty TelecommunicationsCommunications NextGen Communications LLC. provided telephone and communication platforms to small and medium businesses. It specialized in network security and compliance, managed services, cloud computing and unified communications. The company was founded in 2001 and was headquartered in Delmar, NY. | Comptroller/Controller/Auditor | 01-01-2004 |
Ma Laboratories, Inc.
 Ma Laboratories, Inc. Electronics DistributorsDistribution Services Ma Laboratories, Inc. distributes computer components and other consumer electronics. It offers selection of memory, storage products and other hardware and software components for PCs and servers, and consumer electronics. The firm products include CPUs, storage devices, notebooks, motherboards, graphics cards, displays, wireless networking, cases, consumer electronics, software and more. The company was founded in 1983 and is headquartered in San Jose, CA. | Comptroller/Controller/Auditor | - |
| General Bank | Corporate Officer/Principal | - |
Opleiding van Ju Yi Lin
| University of California, Riverside | Masters Business Admin |
| Soochow University /Taiwan/ | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FORMOSA PHARMACEUTICALS, INC. | Health Technology |
| PHARMOSA BIOPHARM INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Ma Laboratories, Inc.
Ma Laboratories, Inc. Electronics DistributorsDistribution Services Ma Laboratories, Inc. distributes computer components and other consumer electronics. It offers selection of memory, storage products and other hardware and software components for PCs and servers, and consumer electronics. The firm products include CPUs, storage devices, notebooks, motherboards, graphics cards, displays, wireless networking, cases, consumer electronics, software and more. The company was founded in 1983 and is headquartered in San Jose, CA. | Distribution Services |
| General Bank | Finance |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
NextGen Communications LLC
NextGen Communications LLC Specialty TelecommunicationsCommunications NextGen Communications LLC. provided telephone and communication platforms to small and medium businesses. It specialized in network security and compliance, managed services, cloud computing and unified communications. The company was founded in 2001 and was headquartered in Delmar, NY. | Communications |
| TLC Biopharmaceuticals, Inc. |
